Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mindray to Hold Annual General Meeting in Shenzhen, China on August 3, 2007 2007-07-16 20:00
Mindray to Report Second Quarter 2007 Financial Results on August 6, 2007 2007-07-16 20:00
FDA Conditional Approval of China Medical Technologies’ Investigational Device Exemption Application 2007-07-16 18:00
Skystar Bio-Pharmaceutical Opens 150 Franchise Showcase Stores 2007-07-16 20:00
Mersana Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran Nicholas G. Bacopoulos, Ph.D. to Board of Directors 2007-07-13 08:33
Synutra Added to Russell 3000 and Russell 2000 Indexes 2007-07-11 10:19
Collexis Selected as Knowledge Platform for the National Institutes of Health 2007-07-11 09:45
Skystar Bio-Pharmaceutical Develops Over 20 New Microorganism Products 2007-07-09 20:00
Pharmaxis Files for Aridol Approval in Korea 2007-07-09 21:00
China Holdings Inc. Announces Appointment of Chairmen of Advisory Board and IR Partners 2007-07-09 11:44
Fuwei Films Announces Date of Second Quarter 2007 Results and Conference Call 2007-07-09 21:00
New Study Shows that Extending Prophylaxis with Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) to 5 Weeks is more Effective than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients with Reduced Mobility 2007-07-09 09:26
China Kangtai Cactus Biotech, Inc. Launches New Products 2007-07-05 21:48
China Sky One Medical Passes Recent SFDA Inspection 2007-07-05 20:00
Pharmaxis Completes Phase III Bronchiectasis Trial 2007-07-05 21:00
China-Biotics, Inc. Retains CCG Elite 2007-07-03 21:00
Panagene Secures License to Commercialize PNA Monomers from PNA Inventor Group 2007-07-03 14:00
3SBio Inc. Announces Filing of Annual Report on Form 20-F 2007-07-02 22:00
International Experts Meet to Discuss Health Threats Due to Global Warming 2007-06-28 12:10
Conference on Tobacco Control Treaty Urged to Adopt 100% Smoke-Free Policies as Global Health Standard 2007-06-28 08:29
1 786 787 788 789 790 800